Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
Burcu Tunakan, Vice President of US Hematology and Endocrinology Franchise Lead at Pfizer, shared a post on LinkedIn:
“Today, we were thrilled to host our second Hemophilia Day at Pfizer Headquarters.
Leading Hematologists across the nation joined us for a day of candid dialogue and collaboration, at a time when the science in this space is advancing faster than ever.
We exchanged perspectives and insights which will shape our team’s actions to advance care for people living with Hemophilia.
Because there is still meaningful work ahead.
And our team is fully committed to turning breakthrough innovation into real, lasting patient impact, by listening deeply and working alongside this community every step of the way.
Thank you to every leading expert who joined us.
Your partnership makes the difference.”
Stay updated with Hemostasis Today.
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants
-
Sep 23, 2026, 12:34Hiteshi K.C. Chauhan: Why Mechanical Valve Thrombosis Is a Systems Failure, Not Just an Anticoagulation Error
-
Sep 23, 2026, 12:33World Thrombosis Day 2026 Puts Women’s Health in Focus – JTH
-
Sep 23, 2026, 12:30Zain Khalpey: How a Sudden Blockage Causes Myocardial Infarction
-
Sep 23, 2026, 12:16Apurva Popat: When Heparin Triggers Thrombosis
-
Sep 23, 2026, 12:14Zahra Ghasemi: The Power of Voluntary Blood Donation
-
Sep 23, 2026, 12:04Leo Nicolai: Activated Platelets Get Trapped in the Spleen During Thrombosis
-
Sep 23, 2026, 12:01Francisco Chacón-Lozsán: Rethinking PE Risk in 2026
-
Sep 23, 2026, 11:58Ifeanyichukwu Ifechidere: Factor V Leiden Requires Context Beyond the Genetic Result